R/CooperStrokedat.R

In nmaINLA: Network Meta-Analysis using Integrated Nested Laplace Approximations

#' Data for the stroke prevention NMA-network discussed in Cooper et al. (2009)
#'
#' The stroke prevention dataset describes a network comparing 17 treatments with 26 trials.
#'
#' @format A data frame with 26 observations on the following 17 variables.
#' \describe{
#' \item{\code{r1}}{Number of events (responses) in the baseline treatment (treatment
#' 1).}
#' \item{\code{r2}}{Number of events (responses) in the second study arm treatment
#' (treatment 2).}
#' \item{\code{r3}}{Number of events (responses) in the third study arm treatment
#' (treatment 3).}
#' \item{\code{r4}}{Number of events (responses) in the third study arm treatment
#' (treatment 4).}
#' \item{\code{r5}}{Number of events (responses) in the third study arm treatment
#' (treatment 5).}
#' \item{\code{n1}}{Total number of study participants in the baseline
#' treatment (treatment 1).}
#' \item{\code{n2}}{Total number of study participants in the second study arm
#' treatment (treatment 2).}
#' \item{\code{n3}}{Total number of study participants in the second study arm
#' treatment (treatment 3).}
#' \item{\code{n4}}{Total number of study participants in the second study arm
#' treatment (treatment 4).}
#' \item{\code{n5}}{Total number of study participants in the second study arm
#' treatment (treatment 5).}
#' \item{\code{t1}}{Indicator variable identifying treatment 1.}
#' \item{\code{t2}}{Indicator variable identifying treatment 2.}
#' \item{\code{t3}}{Indicator variable identifying treatment 3.}
#' \item{\code{t4}}{Indicator variable identifying treatment 4.}
#' \item{\code{t5}}{Indicator variable identifying treatment 5.}
#' \item{\code{na}}{Indicator with number of arms in trial.}
#' \item{\code{cov}}{Covariate, study-specific covariates}
#' \item{\code{des}}{Design, the set of treatments included in each study}
#' }

#' @source Cooper, N.J., Sutton, A.J., Morris, D., Ades, A.E. and Welton, N.J., 2009. Addressing between-study
#' heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments
#'  in individuals with non-rheumatic atrial fibrillation. Statistics in medicine, 28(14), pp.1861-1881.
"CooperStrokedat"